BioSpace News Archive

Amgen (NASDAQ:AMGN) will present at the Cowen 4 th Annual Virtual IO Summit at 3:30 p.m. ET on Friday, November 13, 2020 . David M. Reese , M.D., executive vice president of Research and Development at Amgen will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen’s

Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced a collaboration with GlaxoSmithKline plc (GSK) to use its clonoSEQ ® Assay to assess minimal residual disease (MRD) in GSK’s portfolio of hematology products. “We are thrilled to collaborate with GSK to implement our leadi

Envista Holdings Corporation (NYSE: NVST) (“Envista”) today announced that the company will participate in the Wolfe Research Virtual Healthcare Conference on Wednesday, November 18, 2020 from 10:30 – 11:05 AM ET.